<DOC>
	<DOCNO>NCT00406432</DOCNO>
	<brief_summary>The study design ass steady-state pharmacokinetic profile paroxetine 14 day repeat daily dose control release tablet formulation ( 25 mg ) healthy Chinese subject .</brief_summary>
	<brief_title>A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Inclusion criterion : 1945 year healthy Chinese subject Body weight &gt; 50 kg BMI 1925 serological negative HIV , syphilis hepatitis B C abnormalities ECG Female negative pregnancy male plan child 3 month study . Exclusion criterion : History chronic physical/mental disease , current disease concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>BRL029060/Paroxetine CR</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>repeat dose</keyword>
</DOC>